Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Association between Gene Expression Levels of Candidate Cytarabine Pathway and Treatment Outcome Using Publically Available Data from Target Project

Abdelrahman Elsayed, BSc, MSc, Jatinder Lamba, PhD

Blood (2017) 130 (Supplement 1): 1400.

https://doi.org/10.1182/blood.V130.Suppl_1.1400.1400

Published: 2017

Journal Articles

CD33-Single Nucleotide Polymorphism (CD33-SNP) Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: Report from Children's Oncology Group AAML0531 Trial

Jatinder Lamba, PhD, Lata Chauhan, PhD, Miyoung Shin, PhD, Michael R. Loken, PhD, Jessica A. Pollard, MD, Jim Wang, Richard Aplenc, MD, Betsy A Hirsch, PhD, Susana C. Raimondi, PhD, Roland B. Walter, MD PhD, Irwin D. Bernstein, MD, Alan S Gamis, MD MPH, Todd A Alonzo, PhD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 3826.

https://doi.org/10.1182/blood.V130.Suppl_1.3826.3826

Published: 2017

Journal Articles

CD33 DE2 Transcript Variant Encoded By Splicing Polymorphism Is Devoid of Antibody Binding Site and Lacks Response to CD33 Directed Antibody Drug Conjugates

Katherine Tarlock, MD, Jatinder Lamba, PhD, Soheil Meshinchi, MD PhD

Blood (2017) 130 (Supplement 1): 2661.

https://doi.org/10.1182/blood.V130.Suppl_1.2661.2661

Published: 2017

Journal Articles

Risk Score Generated from Ara-C Metabolic Pathway Predicts Leukemic Cell Intracellular Ara-CTP Levels in AML-97 Pediatric Patients

Abdelrahman Elsayed, BSc, MSc, Kristine R Crews, PharmD, Xueyuan Cao, PhD, Jeffrey E Rubnitz, MD PhD, Stanley Pounds, PhD, Jatinder Lamba, PhD

Blood (2017) 130 (Supplement 1): 2666.

https://doi.org/10.1182/blood.V130.Suppl_1.2666.2666

Published: 2017

Journal Articles

Global and Targeted Metabolic Profiling Identifies Metabolic Markers for FLT3-ITD in Pediatric AML Patients

Bradley Stockard, PharmD, Joy Guingab, PhD, Timothy Garrett, PhD, Stanley Pounds, PhD, Jeffrey E Rubnitz, MD PhD, Jatinder Lamba, PhD

Blood (2017) 130 (Supplement 1): 5105.

https://doi.org/10.1182/blood.V130.Suppl_1.5105.5105

Published: 2017

Journal Articles

Drug Transporter ABCB1 SNP Predicts Outcome in Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozagamicin: A Report from Children's Oncology Group AAML0531 Trial

Lata Chauhan, PhD, Todd A Alonzo, PhD, Jim Wang, Michael R. Loken, PhD, Jessica A. Pollard, MD, Richard Aplenc, MD, Susana C. Raimondi, PhD, Roland B. Walter, MD PhD, Betsy A Hirsch, PhD, Irwin D. Bernstein, MD, Alan S Gamis, MD MPH, Soheil Meshinchi, MD PhD, Jatinder Lamba, PhD

Blood (2017) 130 (Supplement 1): 2526.

https://doi.org/10.1182/blood.V130.Suppl_1.2526.2526

Published: 2017

Journal Articles

Genome-Wide Association Study (GWAS) Identifies SNPs in GPR56 and IGF1R Predictive of Leukemic Cell In Vitro cytarabine Sensitivity in Pediatric AML

Salma Bargal, BSPharm, Roya Rafiee, PhD, Kristine R Crews, PharmD, Xueyuan Cao, PhD, Jeffrey E Rubnitz, MD PhD, Stanley Pounds, PhD, Jatinder Lamba, PhD

Blood (2017) 130 (Supplement 1): 1426.

https://doi.org/10.1182/blood.V130.Suppl_1.1426.1426

Published: 2017

Journal Articles

Microrna Expression and Drug-Induced Changes in Gene Expression Correlate with Ara-C Chemosensitivity in AML Cell Lines

Neha S Bhise, Vishal Lamba, PhD, Jatinder Lamba, PhD

Blood (2014) 124 (21): 3623.

https://doi.org/10.1182/blood.V124.21.3623.3623

Published: 2014

Journal Articles

High-Throughput, High-Content siRNA/Drug Modifier Screen for Validation of Transcriptional Profiles Predictive of Cytarabine Response in AML

Jatinder Lamba, PhD, Lata Chauhan, PhD, Christophe Echeverri, PhD, Kerstin Korn, Kartini Kochar, Xueyuan Cao, PhD, Stanley Pounds, PhD

Blood (2014) 124 (21): 3615.

https://doi.org/10.1182/blood.V124.21.3615.3615

Published: 2014

Journal Articles

Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H -Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines

Lata Chauhan, PhD, Brooke Fridley, Feldberg Tanya, Taraswi Mitra Ghosh, Neha Bhise, Jatinder Lamba, PhD

Blood (2013) 122 (21): 1287.

https://doi.org/10.1182/blood.V122.21.1287.1287

Published: 2013

Journal Articles

A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

Michael J Burke, MD, Jatinder Lamba, PhD, Brenda Weigel, MSc, MD, Veronika Bachanova, MD, Michael R. Verneris, MD, Jeffrey S. Miller, MD

Blood (2012) 120 (21): 4307.

https://doi.org/10.1182/blood.V120.21.4307.4307

Published: 2012

Journal Articles

Clinical Significance of CD33 Non-Synonymous Single Nucleotide Polymorphisms (SNPs) in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozogamicin-Containing Chemotherapy,

Jatinder Lamba, PhD, Leslie J. Mortland, MD, Amit Mitra, Roland B. Walter, MD, PhD, Jessica A. Pollard, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, M.A., Betsy A. Hirsch, PhD, Susana C. Raimondi, PhD, Janet Franklin, MD, MPH, Soheil Meshinchi, MD, PhD

Blood (2011) 118 (21): 3489.

https://doi.org/10.1182/blood.V118.21.3489.3489

Published: 2011

Journal Articles

Pathway Based Pharmacogenomics of Cytarabine In Pediatric Acute Myeloid Leukemia

Jatinder Lamba, PhD, Amit Mitra, Kristine Crews, Pounds Stanley, PhD, Xueyuan Cao, PhD, Varsha Gandhi, PhD, William Plunkett, PhD, Jeffrey Rubnitz, MD, PhD, Raul Ribeiro

Blood (2010) 116 (21): 294.

https://doi.org/10.1182/blood.V116.21.294.294

Published: 2010

Journal Articles

Triptolide Exerts a Cytotoxic Effect on Human Acute Myeloid Leukemia Cell Lines

Jennifer M.H. McCormack, MD, Tanya Feldberg, Jatinder Lamba, PhD

Blood (2010) 116 (21): 4352.

https://doi.org/10.1182/blood.V116.21.4352.4352

Published: 2010

Journal Articles

Deoxycytidine Kinase Genotype Influences Leukemia Cell Concentration of Cytarabine 5′-Triphosphate in Pediatric AML Patients.

Jatinder Lamba, PhD, Kristine Crews, Pharm. D, Stanley Pounds, Ph.D., Erin Schuetz, Ph.D., Varsha Gandhi, Ph.D., William Plunkett, Ph.D., Jeffrey Rubnitz, M.D., Ph.D., Raul Ribeiro, M.D

Blood (2007) 110 (11): 225.

https://doi.org/10.1182/blood.V110.11.225.225

Published: 2007

NARROW

Association between Gene Expression Levels of Candidate Cytarabine Pathway and Treatment Outcome Using Publically Available Data from Target Project

CD33-Single Nucleotide Polymorphism (CD33-SNP) Score Predicts Gemtuzumab Ozogamicin Response in Childhood Acute Myeloid Leukemia: Report from Children's Oncology Group AAML0531 Trial

CD33 DE2 Transcript Variant Encoded By Splicing Polymorphism Is Devoid of Antibody Binding Site and Lacks Response to CD33 Directed Antibody Drug Conjugates

Risk Score Generated from Ara-C Metabolic Pathway Predicts Leukemic Cell Intracellular Ara-CTP Levels in AML-97 Pediatric Patients

Global and Targeted Metabolic Profiling Identifies Metabolic Markers for FLT3-ITD in Pediatric AML Patients

Drug Transporter ABCB1 SNP Predicts Outcome in Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozagamicin: A Report from Children's Oncology Group AAML0531 Trial

Genome-Wide Association Study (GWAS) Identifies SNPs in GPR56 and IGF1R Predictive of Leukemic Cell In Vitro cytarabine Sensitivity in Pediatric AML

Microrna Expression and Drug-Induced Changes in Gene Expression Correlate with Ara-C Chemosensitivity in AML Cell Lines

High-Throughput, High-Content siRNA/Drug Modifier Screen for Validation of Transcriptional Profiles Predictive of Cytarabine Response in AML

Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H -Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines

A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia

Clinical Significance of CD33 Non-Synonymous Single Nucleotide Polymorphisms (SNPs) in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab Ozogamicin-Containing Chemotherapy,

Pathway Based Pharmacogenomics of Cytarabine In Pediatric Acute Myeloid Leukemia

Triptolide Exerts a Cytotoxic Effect on Human Acute Myeloid Leukemia Cell Lines

Deoxycytidine Kinase Genotype Influences Leukemia Cell Concentration of Cytarabine 5′-Triphosphate in Pediatric AML Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only